Ipamorelin and Tesamorelin Interaction

Monitor
Researched 90% confidence

Ipamorelin and Tesamorelin have an interaction requiring monitoring for interaction with 90% confidence. Synergistic GH stimulation; monitor IGF-1 levels. Both compounds affect the gi tract and pituitary, so monitoring these systems is recommended.

Compound Profiles

Ipamorelin

Growth Hormone Secretagogue | Selective GHRP

Binds selectively to ghrelin receptors in pituitary gland, stimulating natural GH release with direct systemic delivery via injection, consistent GH pulse stimulation, no significant cortisol or prolactin elevation, and minimal hunger response..

Half-life: ~2 hours Typical dose: 200-300 mcg per injection growth hormone, weight loss, sleep
ghrelin receptorprolactin receptor carcinogenic riskinsulin disruptingteratogenic
View full profile

Tesamorelin

GHRH Analog | Visceral Fat Reduction

Subcutaneous injection provides optimal bioavailability for GHRH receptor binding and pulsatile GH release stimulation, selectively targeting visceral adipose tissue while sparing subcutaneous fat..

Half-life: 26-38 minutes Typical dose: 1.4-2mg daily (FDA-approved: 2mg for HIV lipodystrophy) growth hormone, weight loss
ghrh receptor carcinogenic riskinsulin disruptingteratogenic
View full profile

Combined Organ Load

GI Tract
low
Pituitary
low
Brain
low

Shared Safety Flags

2x 2 compounds share the carcinogenic-risk safety flag (Ipamorelin, Tesamorelin). Monitor accordingly.
2x 2 compounds affect insulin sensitivity (Ipamorelin, Tesamorelin). Monitor fasting glucose and HbA1c.
2x 2 compounds share the teratogenic safety flag (Ipamorelin, Tesamorelin). Monitor accordingly.

Frequently Asked Questions

Can I take Ipamorelin with Tesamorelin?

Yes, but with caution. Synergistic GH stimulation; monitor IGF-1 levels. Regular monitoring is advised.

Is Ipamorelin and Tesamorelin safe together?

Based on documented research, this combination is considered monitor. However, shared safety flags include: carcinogenic risk, insulin disrupting, teratogenic. Monitor accordingly.

What are the interactions between Ipamorelin and Tesamorelin?

Synergistic GH stimulation; monitor IGF-1 levels. This assessment has 90% confidence and is based on documented research data.

How should I time Ipamorelin and Tesamorelin?

Ipamorelin has a half-life of ~2 hours and Tesamorelin has a half-life of 26-38 minutes. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: Ipamorelin vs Tesamorelin

This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.